Analysts’ Price Target Changes for August 7th (ACAD, ACM, AHR, ATKR, BL, BLDR, BRX, CELH, CRUS, DTI)

Analysts’ price target changes for Wednesday, August 7th:

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price target reduced by Needham & Company LLC from $30.00 to $28.00. The firm currently has a buy rating on the stock.

AECOM (NYSE:ACM) had its price target raised by KeyCorp from $94.00 to $99.00. KeyCorp currently has an overweight rating on the stock.

American Healthcare REIT (NYSE:AHR) had its target price increased by JMP Securities from $16.00 to $18.00. The firm currently has a market outperform rating on the stock.

Atkore (NYSE:ATKR) had its price target cut by KeyCorp from $175.00 to $125.00. They currently have an overweight rating on the stock.

BlackLine (NASDAQ:BL) had its target price cut by BTIG Research from $71.00 to $65.00. BTIG Research currently has a buy rating on the stock.

Builders FirstSource (NYSE:BLDR) had its target price trimmed by Benchmark Co. from $220.00 to $200.00. Benchmark Co. currently has a buy rating on the stock.

Brixmor Property Group (NYSE:BRX) had its price target increased by KeyCorp from $26.00 to $28.00. They currently have an overweight rating on the stock.

Celsius (NASDAQ:CELH) had its target price trimmed by TD Cowen from $68.00 to $50.00. TD Cowen currently has a buy rating on the stock.

Cirrus Logic (NASDAQ:CRUS) had its target price boosted by KeyCorp from $155.00 to $165.00. They currently have an overweight rating on the stock.

Drilling Tools International (NASDAQ:DTI) had its price target lowered by Alliance Global Partners from $8.50 to $7.50. They currently have a buy rating on the stock.

Exelixis (NASDAQ:EXEL) had its price target raised by JMP Securities from $27.00 to $29.00. The firm currently has a market outperform rating on the stock.

Flywire (NASDAQ:FLYW) had its price target cut by BTIG Research from $27.00 to $26.00. They currently have a buy rating on the stock.

Flywire (NASDAQ:FLYW) had its target price trimmed by Citigroup Inc. from $27.00 to $25.00. The firm currently has a buy rating on the stock.

Fortinet (NASDAQ:FTNT) had its price target raised by Citigroup Inc. from $65.00 to $66.00. The firm currently has a neutral rating on the stock.

Illumina (NASDAQ:ILMN) had its target price raised by Citigroup Inc. from $140.00 to $155.00. Citigroup Inc. currently has a buy rating on the stock.

Inspire Medical Systems (NYSE:INSP) had its target price lowered by KeyCorp from $278.00 to $236.00. The firm currently has an overweight rating on the stock.

Jumia Technologies (NYSE:JMIA) had its target price lowered by Benchmark Co. from $14.00 to $11.00. Benchmark Co. currently has a buy rating on the stock.

Minerva Neurosciences (NASDAQ:NERV) had its price target trimmed by HC Wainwright from $7.00 to $5.00. HC Wainwright currently has a neutral rating on the stock.

Olaplex (NASDAQ:OLPX) had its target price boosted by TD Cowen from $1.80 to $2.00. They currently have a hold rating on the stock.

Progyny (NASDAQ:PGNY) had its target price lowered by JMP Securities from $36.00 to $31.00. The firm currently has a market outperform rating on the stock.

Power Integrations (NASDAQ:POWI) had its price target lowered by Benchmark Co. from $90.00 to $78.00. Benchmark Co. currently has a buy rating on the stock.

Porch Group (NASDAQ:PRCH) had its price target cut by Benchmark Co. from $10.00 to $7.00. Benchmark Co. currently has a buy rating on the stock.

Protagonist Therapeutics (NASDAQ:PTGX) had its target price reduced by JMP Securities from $45.00 to $43.00. They currently have a market outperform rating on the stock.

Protagonist Therapeutics (NASDAQ:PTGX) had its price target raised by HC Wainwright from $38.00 to $40.00. HC Wainwright currently has a buy rating on the stock.

Surgery Partners (NASDAQ:SGRY) had its price target reduced by Citigroup Inc. from $38.00 to $36.00. The firm currently has a buy rating on the stock.

Stevanato Group (NYSE:STVN) had its target price cut by Citigroup Inc. from $30.00 to $28.00. They currently have a buy rating on the stock.

Tripadvisor (NASDAQ:TRIP) had its price target trimmed by BTIG Research from $25.00 to $20.00. They currently have a buy rating on the stock.

Uber Technologies (NYSE:UBER) had its price target increased by JMP Securities from $75.00 to $80.00. The firm currently has a market outperform rating on the stock.

Uber Technologies (NYSE:UBER) had its price target raised by Citigroup Inc. from $96.00 to $98.00. They currently have a buy rating on the stock.

Vitesse Energy (NYSE:VTS) had its price target reduced by Alliance Global Partners from $28.00 to $26.00. Alliance Global Partners currently has a buy rating on the stock.

Receive News & Ratings for ACADIA Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACADIA Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.